Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Intellia Therapeutics Inc (NTLA)

323 + Investors. Track Smart Money conviction in NTLA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +24
Streak
4Q ▲
Buyers last Q
63%

Smart Money Signals — NTLA

Based on 329 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added NTLA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
329 hedge funds hold NTLA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +20% more funds vs a year ago

fund count last 6Q
+54 new funds entered over the past year (+20% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 63% buying

200 buying118 selling
Last quarter: 200 funds were net buyers (59 opened a brand new position + 141 added to an existing one). Only 118 were sellers (83 trimmed + 35 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~59 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 49 → 69 → 63 → 59. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 22% medium ■ 23% new
182 out of 329 hedge funds have held NTLA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +68% but shares only +27% — price-driven

Value
+68%
Shares
+26%
Last quarter: the total dollar value of institutional holdings rose +68%, but actual share count only changed +27%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~59 new funds/quarter

41 → 49 → 69 → 63 → 59 new funds/Q
New funds entering each quarter: 49 → 69 → 63 → 59. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 64% veterans vs 24% newcomers

■ 64% veterans ■ 12% 1-2yr ■ 24% new
Entry-cohort mix of 348 holders: 222 (64%) are 2+ year veterans, 42 entered 1–2 years ago, and 84 (24%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 50% AUM from top-100 funds

50% from top-100 AUM funds
54 of 324 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in NTLA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.8
out of 10
Low Exit Risk
Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NTLA

In 2026 Q2, 200 hedge funds were net buyers of NTLA (59 opened a new position, 141 added to an existing one), while 118 reduced or exited (83 trimmed, 35 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 50% of total institutional value in NTLA is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +24 funds (more new holders than closures). Total institutional holders: 329.

Hedge Fund Ownership: NTLA

How many hedge funds hold NTLA — quarterly history vs. share price
Quarterly hedge fund ownership of NTLA vs. share price

Market Analysis: NTLA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NTLA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 2 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
2.1
/ 10
conviction
Hedge Fund Positioning: NTLA
323 + Investors

Track Smart Money conviction in NTLA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 323 305 5.9%
13F Shares 148M 117M 26.91%
Total Value $2.49B $1.48B 68.42%
New Positions 59 63 -4
Increased Positions 136 129 +7
Closed Positions 36 51 -15
Reduced Positions 79 60 +19
Total Calls 14 12 16.67%
Total Puts 9 6 50.0%
PUT/CALL Ratio 0.64 0.5 Bullish

Statistics: NTLA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

323 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NTLA. Verified SEC 13F-HR filings.

QUARTER:
Top 25 NTLA holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Regeneron Pharmaceuticals, INC. 35.35% 3,702,995 $62.7M
2 Birchview Capital, LP 3.17% 385,900 $6.8M
3 ARK Investment Management LLC 1.85% 16,875,684 $285.5M
4 Deuterium Capital Management, LLC 1.83% 100,000 $1.7M
5 Contrarius Group Holdings Ltd 1.52% 1,955,228 $33.1M
6 Orchard Capital Management, LLC 1.31% 79,503 $1.3M
7 Scientech Research LLC 0.99% 72,533 $1.2M
8 IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.84% 777,948 $13.2M
9 Sector Gamma As 0.68% 185,177 $3.1M
10 Ra Capital Management, L.P. 0.67% 4,526,926 $76.6M
11 Amova Asset Management Americas, Inc. 0.63% 2,897,529 $49.0M
12 Elmwood Wealth Management, Inc. 0.44% 102,944 $1.7M
13 Diadema Partners LP 0.43% 200,000 $3.4M
14 Torrey Growth & Income Advisors 0.40% 70,669 $1.2M
15 Ghisallo Capital Management LLC 0.40% 1,200,000 $20.3M
16 Opaleye Management Inc. 0.38% 250,000 $4.2M
17 Himension Capital (singapore) PTE. LTD. 0.34% 326,893 $5.5M
18 Armistice Capital, LLC 0.31% 1,500,000 $25.4M
19 Casdin Capital, LLC 0.30% 355,000 $6.0M
20 Gen-Wealth Partners Inc 0.29% 61,343 $1.0M
21 Generali Investments Towarzystwo Funduszy Inwestycyjnych 0.27% 40,000 $677K
22 Avidity Partners Management LP 0.20% 75,000 $1.3M
23 Wellington Grp LLC 0.18% 46,297 $594K
24 PSP Research LLC 0.18% 20,000 $338K
25 Headlands Technologies LLC 0.17% 94,250 $1.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Intellia Therapeutics Inc (NTLA)

What does the Smart Money Trend signal show for NTLA?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added NTLA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NTLA?

More buyers than sellers — 63% buying: Last quarter: 200 funds were net buyers (59 opened a brand new position + 141 added to an existing one). Only 118 were sellers (83 trimmed + 35 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for NTLA holders?

Elite ownership — 50% AUM from top-100 funds: 54 of 324 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in NTLA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held NTLA?

55% of holders stayed for 2+ years: 182 out of 329 hedge funds have held NTLA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →